drugset / Trial / NCT04633928
Nasal Septum Perforation Treatment Using Tissue Engineered Cartilage Graft
Phase 1
Completed
5 enrolled
University Hospital, Basel, Switzerland
Dr Josef Vavrina, HNO Seepraxen, CH-8810 Horgen, Zurich · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate the safety and feasibility of implanting an engineered cartilage tissue in an interposition graft with a temporoparietal fascia (TPF) flap to repair medium size septal perforation. The engineered cartilage graft is obtained by culturing expanded autologous nasal chondrocytes within a collagen type I/III membrane. In addition, first data on efficacy will be collected.
Timeline
- Start
- 2021-04-09
- Primary completion
- 2023-04-24
- Completion
- 2023-04-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | N-TEC | Unknown | — | Other |
Indications
No indication recorded.